Rather than pharmacokinetic advantage, measured by the AUCratio of perfusate concentration of drug times time to plasmaconcentration times time, the uptake of chemotherapy by tumortissue has been proposed as the best pharmacologic endpoint toassure the efficacy of HIPEC